HY-105999B-1mg
|
MedChemexpress LLC
|
APC 366 (TFA) [CAS 2421110-28-1]
|
|
|
|
HY-105999-5mg
|
MedChemexpress LLC
|
APC 366 [CAS 158921-85-8]
|
|
COVID-19-immunoregulation
|
|
HY-110287-1mg
|
MedChemexpress LLC
|
Apcin [CAS 300815-04-7]
|
|
Cancer-programmed cell death
|
|
HY-110287-10mg
|
MedChemexpress LLC
|
Apcin [CAS 300815-04-7]
|
|
Cancer-programmed cell death
|
|
HY-110287-100mg
|
MedChemexpress LLC
|
Apcin [CAS 300815-04-7]
|
|
Cancer-programmed cell death
|
|
HY-110287-25mg
|
MedChemexpress LLC
|
Apcin [CAS 300815-04-7]
|
|
Cancer-programmed cell death
|
|
HY-110287-5mg
|
MedChemexpress LLC
|
Apcin [CAS 300815-04-7]
|
|
Cancer-programmed cell death
|
|
HY-110287-50mg
|
MedChemexpress LLC
|
Apcin [CAS 300815-04-7]
|
|
Cancer-programmed cell death
|
|
HY-110287-1mL
|
MedChemexpress LLC
|
Apcin [CAS 300815-04-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-130841-10mg
|
MedChemexpress LLC
|
Apcin-A [CAS 1683617-62-0]
|
|
Cancer-programmed cell death
|
|
HY-130841-100mg
|
MedChemexpress LLC
|
Apcin-A [CAS 1683617-62-0]
|
|
Cancer-programmed cell death
|
|
HY-130841-25mg
|
MedChemexpress LLC
|
Apcin-A [CAS 1683617-62-0]
|
|
Cancer-programmed cell death
|
|
HY-130841-5mg
|
MedChemexpress LLC
|
Apcin-A [CAS 1683617-62-0]
|
|
Cancer-programmed cell death
|
|
HY-130841-50mg
|
MedChemexpress LLC
|
Apcin-A [CAS 1683617-62-0]
|
|
Cancer-programmed cell death
|
|
HY-130841-1mL
|
MedChemexpress LLC
|
Apcin-A [CAS 1683617-62-0] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-P74382-10ug
|
MedChemexpress LLC
|
Beta-Catenin, Human (sf9, His-GST)
|
|
|
|
HY-P74382-5ug
|
MedChemexpress LLC
|
Beta-Catenin, Human (sf9, His-GST)
|
|
|
|
HY-P74382-50ug
|
MedChemexpress LLC
|
Beta-Catenin, Human (sf9, His-GST)
|
|
|
|
HY-P78753-10ug
|
MedChemexpress LLC
|
CD3 gamma, Human (HEK293, Fc)
|
|
|
|
HY-P78753-5ug
|
MedChemexpress LLC
|
CD3 gamma, Human (HEK293, Fc)
|
|
|
|
HY-P78753-50ug
|
MedChemexpress LLC
|
CD3 gamma, Human (HEK293, Fc)
|
|
|
|
HY-103255-10mg
|
MedChemexpress LLC
|
CFM-4 [CAS 331458-02-7]
|
|
Cancer-programmed cell death
|
|
HY-103255-25mg
|
MedChemexpress LLC
|
CFM-4 [CAS 331458-02-7]
|
|
Cancer-programmed cell death
|
|
HY-103255-5mg
|
MedChemexpress LLC
|
CFM-4 [CAS 331458-02-7]
|
|
Cancer-programmed cell death
|
|
HY-P99933-1mg
|
MedChemexpress LLC
|
Eftilagimod alfa [CAS 1800476-36-1]
|
|
Cancer-programmed cell death
|
|